|

152 microCi of 225Ac-MTI-201 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 152 microCi 225Actinium-MTI-201

Tampa, Florida1 trial

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.